(Q43166811)
Statements
Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis (English)
Karima Chaoui
Bernard Monsarrat
Florence Dalenc
Sophie F Doisneau-Sixou
Sabrina Marsili
Valérie Lauwers-Cances
Odile Schiltz
Nicole Renée
Emilie Malissein
Elise Meunier